Jones Financial Companies’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.14M Buy
28,179
+2,035
+8% +$250K ﹤0.01% 1272
2026
Q1
$2.88M Buy
26,144
+23,341
+833% +$3.26M ﹤0.01% 1281
2025
Q4
$459K Sell
2,803
-509
-15% -$79.7K ﹤0.01% 1558
2025
Q3
$416K Buy
3,312
+750
+29% +$91.1K ﹤0.01% 1470
2025
Q2
$317K Buy
2,562
+2,398
+1,462% +$305K ﹤0.01% 1466
2025
Q1
$21.9K Buy
164
+2
+1% +$308 ﹤0.01% 2394
2024
Q4
$23.3K Sell
162
-21
-11% -$3.01K ﹤0.01% 2189
2024
Q3
$26.7K Buy
183
+82
+81% +$11.8K ﹤0.01% 1855
2024
Q2
$12.7K Buy
101
+46
+84% +$7.21K ﹤0.01% 1679
2024
Q1
$10.1K Buy
+55
New +$10.5K ﹤0.01% 1062

Other funds holding RGEN

Jones Financial Companies's RGEN Position: Q2 2026 in Review

Jones Financial Companies increased its Repligen (RGEN) stake by 7.8% in Q2 2026, buying an estimated $250K and bringing the position to 28,179 shares worth $4.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1272.

Jones Financial Companies first reported a position in RGEN in Q1 2024 and has held it in 10 quarters since. 477 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Jones Financial Companies held 28,179 shares of Repligen worth $4.14M as of Q2 2026.
  • Jones Financial Companies bought 2,035 Repligen shares in Q2 2026, an estimated $250K.
  • Repligen made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #1272 holding.
  • Jones Financial Companies first reported a position in Repligen in Q1 2024 and has held it in 10 quarters since.
  • 477 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.